×
About 1,061 results

AllMedicine Sputum Culture Center

Research & Reviews  497 results

Time to Sputum Culture Conversion and Treatment Outcomes Among Patients with Isoniazid-...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5850645
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America; Schechter MC, Bizune D et. al.

Oct 11th, 2017 - Although isoniazid-resistant tuberculosis is more common than multidrug-resistant tuberculosis, it has been much less studied. We examined the impact of isoniazid resistance and treatment regimen, including use of a fluoroquinolone, on clinical ou...

Microbiological and Clinical Outcomes of Treating Non-Mycobacterium Avium Complex Nontu...
https://doi.org/10.1016/j.chest.2017.04.166
Chest Diel R, Ringshausen F et. al.

May 3rd, 2017 - Pulmonary disease caused by nontuberculous mycobacteria (NTM) is steadily increasing worldwide. A systematic review of non-Mycobacterium avium complex studies published prior to October 2016 was conducted with respect to microbiological and clinic...

Bacterial flora in the sputum and comorbidity in patients with acute exacerbations of C...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4671781
International Journal of Chronic Obstructive Pulmonary Disease; Boixeda R, Almagro P et. al.

Dec 14th, 2015 - To determine in patients admitted with an acute exacerbation of chronic obstructive pulmonary disease (AE-COPD) the association between the isolation of potential pathogens in a conventional sputum culture and comorbidities. The ESMI study is a mu...

Adjunctive vitamin D for treatment of active tuberculosis in India: a randomised, doubl...
https://doi.org/10.1016/S1473-3099(15)70053-8
The Lancet. Infectious Diseases; Daley P, Jagannathan V et. al.

Apr 12th, 2015 - Vitamin D has immunomodulatory effects that might aid clearance of mycobacterial infection. We aimed to assess whether vitamin D supplementation would reduce time to sputum culture conversion in patients with active tuberculosis. We did this rando...

Clofazimine for the treatment of multidrug-resistant tuberculosis: prospective, multice...
https://doi.org/10.1093/cid/civ027
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America; Tang S, Yao L et. al.

Jan 21st, 2015 - Clofazimine (Cfz) has shown activity against Mycobacterium tuberculosis, including multidrug-resistant (MDR) strains in vitro and in animal studies. Here we evaluate the clinical efficacy and tolerability of using Cfz to treat MDR tuberculosis in ...

see more →

Guidelines  1 results

Provisional CDC guidelines for the use and safety monitoring of bedaquiline fumarate (S...
https://www.ncbi.nlm.nih.gov/pubmed/24157696
MMWR. Recommendations and Reports : Morbidity and Mortality Weekly Report. Recommendations and Reports;

Oct 25th, 2013 - Multidrug-resistant tuberculosis (MDR TB) is caused by Mycobacterium tuberculosis that is resistant to at least isoniazid and rifampin, the two most effective of the four first-line TB drugs (the other two drugs being ethambutol and pyrazinamide)....

see more →

Drugs  1 results see all →

Clinicaltrials.gov  531 results

Time to Sputum Culture Conversion and Treatment Outcomes Among Patients with Isoniazid-...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5850645
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America; Schechter MC, Bizune D et. al.

Oct 11th, 2017 - Although isoniazid-resistant tuberculosis is more common than multidrug-resistant tuberculosis, it has been much less studied. We examined the impact of isoniazid resistance and treatment regimen, including use of a fluoroquinolone, on clinical ou...

Microbiological and Clinical Outcomes of Treating Non-Mycobacterium Avium Complex Nontu...
https://doi.org/10.1016/j.chest.2017.04.166
Chest Diel R, Ringshausen F et. al.

May 3rd, 2017 - Pulmonary disease caused by nontuberculous mycobacteria (NTM) is steadily increasing worldwide. A systematic review of non-Mycobacterium avium complex studies published prior to October 2016 was conducted with respect to microbiological and clinic...

Bacterial flora in the sputum and comorbidity in patients with acute exacerbations of C...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4671781
International Journal of Chronic Obstructive Pulmonary Disease; Boixeda R, Almagro P et. al.

Dec 14th, 2015 - To determine in patients admitted with an acute exacerbation of chronic obstructive pulmonary disease (AE-COPD) the association between the isolation of potential pathogens in a conventional sputum culture and comorbidities. The ESMI study is a mu...

Adjunctive vitamin D for treatment of active tuberculosis in India: a randomised, doubl...
https://doi.org/10.1016/S1473-3099(15)70053-8
The Lancet. Infectious Diseases; Daley P, Jagannathan V et. al.

Apr 12th, 2015 - Vitamin D has immunomodulatory effects that might aid clearance of mycobacterial infection. We aimed to assess whether vitamin D supplementation would reduce time to sputum culture conversion in patients with active tuberculosis. We did this rando...

Clofazimine for the treatment of multidrug-resistant tuberculosis: prospective, multice...
https://doi.org/10.1093/cid/civ027
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America; Tang S, Yao L et. al.

Jan 21st, 2015 - Clofazimine (Cfz) has shown activity against Mycobacterium tuberculosis, including multidrug-resistant (MDR) strains in vitro and in animal studies. Here we evaluate the clinical efficacy and tolerability of using Cfz to treat MDR tuberculosis in ...

see more →

News  31 results

Community-Acquired Pneumonia (CAP) Clinical Practice Guidelines (2019)
https://www.medscape.com/viewarticle/920604

Nov 3rd, 2019 - The Infectious Diseases Society of America (IDSA) and American Thoracic Society (ATS) issued clinical practice guidelines for community-acquired pneumonia (CAP) in adults in October 2019.[1] Diagnosis Gram stain and sputum culture Routine sputum c...

Adding Vitamin D No Help in Treating TB
https://www.medpagetoday.com/infectiousdisease/tuberculosis/77934

Feb 9th, 2019 - Vitamin D supplementation in addition to antimicrobial therapy for tuberculosis had no effect on time to sputum culture for patients with tuberculosis, but cut time to sputum culture conversion for multi-drug resistant patients, according to a sys...

'Limited' Data an Issue with Inhaled Liposomal Amikacin
https://www.medpagetoday.com/pulmonology/generalpulmonary/74430

Aug 6th, 2018 - When FDA advisors assess amikacin liposome inhaled suspension (ALIS) as part of a combination antibacterial drug regimen for the treatment of non-tuberculous mycobacterial lung disease, they will address questions on limited efficacy data, safety ...

The Role of Methicillin-Resistant Staphylococcus aureus Polymerase Chain Reaction Nasal Swabs in Clinical Decision Making
https://www.mdedge.com/fedprac/article/143664/hospital-medicine/role-methicillin-resistant-staphylococcus-aureus-polymerase/page/0/1

Aug 18th, 2017 - Pneumonia has many potential causative organisms, many of which are covered empirically with guideline-directed therapy. The predictive power of MRSA PCR nasal swabs may allow clinicians to prescribe earlier directed therapy.

Six Drugs Ideal for Treating Multidrug-Resistant TB
https://www.medscape.com/viewarticle/856795

Jan 5th, 2016 - For patients with multidrug-resistant tuberculosis (TB), taking at least six potentially effective drugs, particularly including pyrazinamide, significantly increased the likelihood of achieving a sputum culture conversion, according to a prospect...

see more →